For: | Han SW, Roman J. Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer. World J Biol Chem 2010; 1(3): 31-40 [PMID: 21537367 DOI: 10.4331/wjbc.v1.i3.31] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v1/i3/31.htm |
Number | Citing Articles |
1 |
Tuyen N. M. Hua, Jun Namkung, Ai N. H. Phan, Vu T. A. Vo, Min-Kyu Kim, Yangsik Jeong, Jong-Whan Choi. PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation. Journal of Receptors and Signal Transduction 2018; 38(3): 191 doi: 10.1080/10799893.2018.1468781
|
2 |
Suresha N. Deveshegowda, Ji-Rui Yang, Zhang Xi, Omantheswara Nagaraja, Kashifa Fazl-Ur-Rahman, Bhanuprakash C. Narasimhachar, Gautam Sethi, Ganga Periyasamy, Mahendra Madegowda, Shobith Rangappa, Vijay Pandey, Peter E. Lobie, Basappa Basappa. Nano-ZrO2-Catalyzed Biginelli Reaction and the Synthesis of Bioactive Dihydropyrimidinones That Targets PPAR-γ in Human Breast Cancer Cells. Catalysts 2023; 13(2): 228 doi: 10.3390/catal13020228
|
3 |
Han Zhao, Huihui Gu, Han Zhang, Jun-Hui Li, Wen-En Zhao. PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone. Biochimica et Biophysica Acta (BBA) - General Subjects 2014; 1840(1): 545 doi: 10.1016/j.bbagen.2013.09.005
|
4 |
Jingjing Li, Yi-Ping Liu. The roles ofPPARsin human diseases. Nucleosides, Nucleotides & Nucleic Acids 2018; 37(7): 361 doi: 10.1080/15257770.2018.1475673
|
5 |
Ting Zhao, Hong Du, Janice S. Blum, Cong Yan. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis. Oncotarget 2016; 7(2): 1529 doi: 10.18632/oncotarget.6414
|
6 |
Łukasz Uram, Aleksandra Filipowicz, Maria Misiorek, Natalia Pieńkowska, Joanna Markowicz, Elżbieta Wałajtys-Rode, Stanisław Wołowiec. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines. European Journal of Pharmaceutical Sciences 2018; 124: 1 doi: 10.1016/j.ejps.2018.08.019
|
7 |
Monica Mangoni, Mariangela Sottili, Chiara Gerini, Pierluigi Bonomo, Anna Bottoncetti, Francesca Castiglione, Ciro Franzese, Sara Cassani, Daniela Greto, Tatiana Masoni, Icro Meattini, Stefania Pallotta, Alessandro Passeri, Alberto Pupi, Eleonora Vanzi, Giampaolo Biti, Lorenzo Livi. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model. Lung Cancer 2015; 90(3): 405 doi: 10.1016/j.lungcan.2015.11.005
|
8 |
Mohamed A. Abdelgawad, Khaled El-Adl, Sanadelaslam S. A. El-Hddad, Mostafa M. Elhady, Nashwa M. Saleh, Mohamed M. Khalifa, Fathalla Khedr, Mohamed Alswah, AbdElAziz A. Nayl, Mohammed M. Ghoneim, Nour E. A. Abd El-Sattar. Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists. Pharmaceuticals 2022; 15(2): 226 doi: 10.3390/ph15020226
|
9 |
Jun Guo, Jue Wu, Qinyuan He, Mengshu Zhang, Hong Li, Yanping Liu. The Potential Role of PPARs in the Fetal Origins of Adult Disease. Cells 2022; 11(21): 3474 doi: 10.3390/cells11213474
|
10 |
Tae Woo Kim, Da-Won Hong, Chang-Mo Kang, Sung Hee Hong. A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells. Experimental & Molecular Medicine 2020; 52(10): 1730 doi: 10.1038/s12276-020-00511-9
|